SCHEMBL31546204

SCHEMBL31546204

CCCCCC(C)C(C)c1cc(OC)c2c(c1)OC(C)(C)C=C2C1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 7/20 0.34
▸ CNR1 P21554 6/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11880805 0.87 KDR (0.36) CNR2CNR1
SCHEMBL31545470 0.86 KDR (0.38) CNR2CNR1
SCHEMBL31545447 0.76 KDR (0.36) CNR2CNR1
SCHEMBL11796295 0.73 CNR2 (0.33) CNR2CNR1
SCHEMBL31544848 0.72 CNR1 (0.42) CNR2CNR1
SCHEMBL31545038 0.70 CNR2 (0.51) CNR2CNR1
SCHEMBL11638949 0.69 CNR2 (0.34) CNR2CNR1
SCHEMBL11323658 0.69 CNR2 (0.43) CNR2CNR1
SCHEMBL11639583 0.68 — —
SCHEMBL11637204 0.66 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250090554-A1 A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION MYND LIFE SCIENCES INC (CA) 2025-03-20 — — US disclosed
Send feedback